• Home
  • Contact
(800) 605-8422 Toll Free
Diagnomics
×
  • Consumer Genomics Solutions
  • Analysis Platform
    • MICROARRAY
    • NGS
    • OPENARRAY
  • Research Services
    • CLINICAL/TRANSLATION RESEARCH
    • ASSAY DEVELOPMENT
    • Bioinformatics
    • Diagnomics on Cloud
    • My AccuGenie
  • News
    • Diagnomics
    • Amazing Science
  • About us
    • Terms of Service
    • Privacy Policy

Dr. Min-Jeong Kim

Vice-President

Dr. Min-Jeong Kim is Diagnomics’ Vice-President of Genomics and Molecular Medicine. He has supervised clinical laboratory operations under US CAP / CLIA regulation form over 8 years. He is well versed in molecular diagnostics, functional genomics, and molecular medicine. He has been overseeing the R&D laboratory at Diagnomics since 2017, after being the R&D director at our EONE-Diagnomics Genome Center (EDGC) in Incheon, Korea for over 2 years. Before, he served as the director of the Genomics facility at the Ohio University in Athens, OH. He obtained his PhD in Agricultural Biotechnology at the Seoul National University and his postdoctoral training at the Institute of Biological Chemistry at the Washington State University, WA. He published more than 10 scientific journal articles and is the author of several international patents.

Dr. Min-Jeong Kim

Latest Posts

  • Diagnomics Releases Cardiovascular Health Panel on Clinical Microarray PlatformOct 7

    SAN DIEGO, October 7, 2019 (Newswire.com) -​Diagnomics Inc., a San Diego-based genetic testing company, is releasing a cardiovascular-focused genetic report…

  • Visit our booth #643 at ASHG 2019, October 15-17 in Houson!Sep 16

    Don't miss out the largest human genetics meeting in the world - ASHG 2019 in Houston!   [About the ASHG…

  • Diagnomics Added CLIA Certificates From Maryland, Pennsylvania, and Rhode IslandSep 9

    Diagnomics, a leading genomics services provider, announced that it now has active CLIA certifications in three states: Maryland, Pennsylvania, and…

  • Visit our booth #1107 at ACMG 2019, April 3 - 5 in Seattle!Mar 20

     

  • Diagnomics Introduces ACMG 59 Reports for Personalized Genetic TestingJan 29

    Diagnomics, a leading genetic testing company, has developed a new ACMG 59 report that is available to healthcare providers and…

Diagnomics Mission

Diagnomics Mission

Diagnomics, Inc. is a trusted provider of innovative genetic testing platforms for both organizations and individual consumers. We strive to deliver confidence and reliability by offering comprehensive genomic solutions for the development of personalized healthcare and precision medicine in the global genomics market.

Diagnomics is a CLIA-certified, CAP-accredited, and HIPAA-compliant laboratory providing genetic testing platform services and cloud-based analysis solutions.

(800) 605-8422

info@diagnomics.com

www.diagnomics.com

5050 Murphy Canyon Rd ste 150, San Diego, CA 92123

Latest News

  • Diagnomics Releases Cardiovascular Health Panel on Clinical Microarray Platform Oct 7

    SAN DIEGO, October 7, 2019 (Newswire.com) –​Diagnomics Inc., a San...

  • Visit our booth #643 at ASHG 2019, October 15-17 in Houson! Sep 16

    Don’t miss out the largest human genetics meeting in the...

  • Diagnomics Added CLIA Certificates From Maryland, Pennsylvania, and Rhode Island Sep 9

    Diagnomics, a leading genomics services provider, announced that it now...

  • Visit our booth #1107 at ACMG 2019, April 3 – 5 in Seattle! Mar 20

     

Legal Info

Research Consent
Copyright ©2018 all rights reserved
Diagnomics, Inc.